A recent presentation at NUTRITION 2026 in National Harbor, MD, examined whether the FDA's 2021 Voluntary Sodium Reduction Goals translated into lower sodium levels in newly introduced foods across major...
Although pharmacologic management remains central for treating metabolic syndrome, modifiable behavioral patterns are increasingly important in risk reduction counseling.
Novel therapies are reshaping how clinicians think about triglyceride management and residual cardiovascular risk. This quick quiz tests your knowledge of the emerging data on APOC3 inhibition and its...
Throughout this winter season our editorial team has brought you timely, evidence-based coverage that spanned clinical research, practice challenges, expert insights, and interactive learning. In this...
This year we’ve explored critical clinical insights, cutting-edge care strategies, and expert perspectives on our podcast. Today, we’re excited to count down the five standout podcast episodes that...
A 2025 review in the Journal of Clinical Lipidology proposes a North American diagnostic score to help identify familial chylomicronemia syndrome. Can you recognize its key features?